References
- Goldman JD, Julian K. Urinary tract infections in solid organ
transplant recipients: Guidelines from the American Society of
Transplantation Infectious Diseases Community of Practice. Clin
Transplant. 2019 ;33(9):e13507. doi: 10.1111/ctr.13507
- Bodro M, Linares L, Chiang D, Moreno A, Cervera C. Managing recurrent
urinary tract infections in kidney transplant patients. Expert Rev
Anti Infect Ther. 2018; 16(9):723-732. doi:
10.1080/14787210.2018.1509708.
- Kotagiri P, Chembolli D, Ryan J, Hughes PD, Toussaint ND. Urinary
Tract Infections in the First Year Post-Kidney Transplantation:
Potential Benefits of Treating Asymptomatic Bacteriuria. Transplant
Proc. 2017; 49(9):2070-2075.
- Ariza‐Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable
RR. Urinary tract infections in kidney transplant recipients: role of
gender, urologic abnormalities, and antimicrobial prophylaxis. Ann
Transplant. 2013; 18: 195‐204
- Gozdowska J, Czerwińska M, Chabros Ł, et al. Urinary tract infections
in kidney transplant recipients hospitalized at a transplantation and
nephrology ward: 1‐year follow‐up. Transplant Proc.
2016;48(5):1580‐1589
- Michail Alevizakos , Dimitrios Nasioudis , Eleftherios Mylonakis.
Urinary Tract Infections Caused by ESBL-producing Enterobacteriaceae
in Renal Transplant Recipients: A Systematic Review and Meta-Analysis.
Transpl Infect Dis. 2017;19(6). doi: 10.1111/tid.12759
- Vidal E, Torre-Cisneros J, Blanes M, Montejo M, Cervera C, Aguado JM,
Len O, Carratalá J, Cordero E, et al; Spanish Network for Research in
Infectious Diseases (REIPI). Bacterial urinary tract infection after
solid organ transplantation in the RESITRA cohort. Transpl Infect Dis.
2012;14(6):595-603
- Parasuraman R, Julian K; AST Infectious Diseases Community of
Practice. Urinary tract infections in solid organ transplantation. Am
J Transplant. 2013;13 Suppl 4:327-36.
- Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG. Urinary
tract infection caused by extended‐spectrum beta‐lactamase‐ producing
bacteria in kidney transplant patients. Transplant Proc. 2010;
42(2):486‐487.
- Bodro M, Sanclemente G, Lipperheide I, et al. Impact of antibiotic
resistance on the development of recurrent and relapsing symptomatic
urinary tract infection in kidney recipients. Am J Transplant.
2015;15(4):1021‐1027.
- Delmas-Frenette C, Dorais M, Tavares-Brum A, et al. Epidemiology and
outcome of antimicrobial resistance to gram-negative pathogens in
bacteriuric kidney transplant recipients. Transpl Infect Dis. 2017;
19(4): 10.1111/tid.12722. doi:10.1111/tid.12722
- Britt NS, Hagopian JC, Brennan DC, et al. Effects of recurrent urinary
tract infections on graft and patient outcomes after kidney
transplantation. Nephrol Dial Transplant. 2017;32(10):1758‐1766.
doi:10.1093/ndt/gfx237
- Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant,
extensively drug-resistant and pandrug-resistant bacteria: an
international expert proposal for interim standard definitions for
acquired resistance. Clin. Microbiol. Infect. 2012; 18: 268–81.
- Naik AS, Dharnidharka VR, Schnitzler MA, et al. Clinical and economic
consequences of first-year urinary tract infections, sepsis, and
pneumonia in contemporary kidney transplantation practice. Transpl
Int. 2016;29(2):241‐252.
- Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Urinary tract
infections during the first year after renal transplantation: one
center’s experience and a review of the literature. Clin Transplant.
2014;28(11):1263‐1270.
- Visser IJ, van der Staaij JPT, Muthusamy A, Willicombe M, Lafranca JA,
Dor FJMF. Timing of Ureteric Stent Removal and Occurrence of
Urological Complications after Kidney Transplantation: A Systematic
Review and Meta-Analysis. J Clin Med. 2019;8(5):689.
- Cai JF, Wang W, Hao W, et al. Meta-analysis of Early Versus Late
Ureteric Stent Removal After Kidney Transplantation. Transplant Proc.
2018;50(10):3411‐3415.
- Olenski S, Scuderi C, Choo A, et al. Urinary tract infections in renal
transplant recipients at a quaternary care centre in Australia. BMC
Nephrol. 2019;20(1):479.
- Kiros T, Asrat D, Ayenew Z, Tsige E. Bacterial urinary tract infection
among adult renal transplant recipients at St. Paul’s hospital
millennium medical college, Addis Ababa, Ethiopia. BMC Nephrol.
2019;20(1):289.
- Yuan X, Liu T, Wu D, Wan Q. Epidemiology, susceptibility, and risk
factors for acquisition of MDR/XDR gram-negative bacteria among kidney
transplant recipients with urinary tract infections. Infect Drug
Resist. 2018;14(11):707–15.
- Brakemeier S, Taxeidi SI, Zukunft B, et al. Extended-Spectrum
Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract
Infection in Kidney Transplant Recipients: Risk Factors, Treatment,
and Long-Term Outcome. Transplant Proc. 2017;49(8):1757‐1765.
- Dantas SR, Kuboyama RH, Mazzali M, Moretti ML. Nosocomial infections
in renal transplant patients: risk factors and treatment implications
associated with urinary tract and surgical site infections. J Hosp
Infect. 2006;63(2):117‐123. doi:10.1016/j.jhin.2005.10.018
- Bodro M, Sanclemente G, Lipperheide I, et al. Impact of urinary tract
infections on short-term kidney graft outcome. Clin Microbiol Infect.
2015; 21(12):1104.e1‐1104.e11048.
- Pilmis B, Scemla A, Join-Lambert O, et al. ESBL-producing
enterobacteriaceae-related urinary tract infections in kidney
transplant recipients: incidence and risk factors for recurrence.
Infect Dis (Lond). 2015;47(10):714‐718.
- Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric
antibiotic therapy in urinary tract infection in patients with risk
factors for antibiotic resistance in a German emergency department.
BMC Infect Dis. 2018;18(1):56.
- Almomani BA, Hayajneh WA, Ayoub AM, Ababneh MA, Al Momani MA. Clinical
patterns, epidemiology and risk factors of community-acquired urinary
tract infection caused by extended-spectrum beta-lactamase producers:
a prospective hospital case-control study. Infection.
2018;46(4):495‐501.
- Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, et al.
Epidemiology, risk factors and comorbidity for urinary tract
infections caused by extended-spectrum beta-lactamase (ESBL)-producing
enterobacteria. Int J Clin Pract. 2012;66(9):891‐896.
Table 1. Demographic and clinical data in patients with or without
urinary tract infections (UTI)